Pregnancy outcome following use of large doses of vitamin B6 in the first trimester

Journal of Obstetrics and Gynaecology

Volumn 26, Issue 8, 2006, Pages 749-751

  Shrim, A ^a   Boskovic, R ^a   Maltepe, C ^a   Navios, Y ^a   Garcia Bournissen, F ^a   Koren, G ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENDECTIN;

ARTICLE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; FEMALE; FETUS; FETUS DEATH; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MORNING SICKNESS; NEUROPATHY; NEWBORN; OBSERVATIONAL STUDY; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SPONTANEOUS ABORTION;

ADULT; ANTIEMETICS; BIRTH WEIGHT; FEMALE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; VITAMIN B 6;

EID: 33845337675     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610600955826     Document Type: Article

References (11)

1. Atanackovic G, Navioz Y, Moretti ME, Koren G. 2001. The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy. Journal of Clinical Pharmacology 41:842-845.
2. Canadian Pharmacists Association. 1999. CPS - Compendium of Pharmaceuticals and Specialties. Canada: Canadian Pharmacists Association.
3. Cohen M, Bendich A. 1986. Safety of pyridoxine - a review of human and animal studies. Toxicology Letters 34:129-139.
4. Einarson TR, Leeder JS, Koren G. 1988. A method for meta-analysis of epidemiological studies. Drug Intelligence and Clinical Pharmacy 22:813-824.
5. Furneaux EC, Langley-Evans AJ, Langley-Evans SC. 2001. Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome. Obstetrics and Gynecology Surveys 56:775-782.
6. Gadsby R, Barnie-Adshead AM, Jagger C. 1993. A prospective study of nausea and vomiting during pregnancy. British Journal of General Practice 43:245-248.
7. McKeigue PM, Lamm SH, Linn S, Kutcher JS. 1994. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology 50:27-37.
8. Neutel CI. 2000. Variation in rates of hospitalization for excessive vomiting in pregnancy by Bendectin 'Diclectin' use in Canada. In: Koren G, Bishai R, editors. Nausea and vomiting of pregnancy: State of the art 2000. Toronto: Motherisk. pp 54-59.
9. 6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstetrics and Gynecology 78:33-36.
10. Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D et al. 1983. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. New England Journal of Medicine 309:445-448.
11. Vutyavanich T, Wongtra-ngan S, Ruangsri R. 1995. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology 173:881-884.